Dexpramipexole [dexpramipexol]
topical
- Terms
-
(6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazol-diamin
(R)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazol
(R)-pramipexol
KNS 760704
KNS-760704
KNS760704
pramipexol, (R)-izomer
R-(+)-pramipexol
SND 919CL2x
SND-919CL2x
SND919CL2x
-
(6R)-4,5,6,7-Tetrahydro-N6-Propyl-2,6-Benzothiazole-Diamine
(R)-2-Amino-6-Propylamino-4,5,6,7-Tetrahydrobenzothiazole
(R)-Pramipexole
KNS 760704
KNS-760704
KNS760704
Pramipexol, (R)-isomer
R-(+)-Pramipexole
SND 919CL2x
SND-919CL2x
SND919CL2x
Persistent link
https://www.medvik.cz/link/D000097662
Definition
The (R)-(+) enantiomer of PRAMIPEXOLE. Dexpramipexole has lower affinity for DOPAMINE RECEPTORS than pramipexole.
- DUI
- D000097662 MeSH Browser
- CUI
- M000607801
- History note
- 2024; use PRAMIPEXOLE 2019-2023
- Public note
- 2024; see PRAMIPEXOLE 2019-2023
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use
- TO
- toxicity
- UR
- urine
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.708.089.111
Dexpramipexole
D03.383.129.708.089.416
Ethoxzolamide
D03.633.100.185.111
Dexpramipexole
D03.633.100.185.416
Ethoxzolamide